Atom Investors LP Uro Gen Pharma Ltd. Transaction History

Atom Investors LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$12.72 - $19.2 $1.21 Million - $1.82 Million	94,990 Added 190.78%	144,780 $2.43 Million
Q1 2024 May 15, 2024	SELL	$13.81 - $19.33 $143,278 - $200,548	-10,375 Reduced 17.24%	49,790 $746,000
Q4 2023 Feb 14, 2024	BUY	$10.87 - $15.93 $483,769 - $708,964	44,505 Added 284.2%	60,165 $902,000
Q3 2023 Nov 14, 2023	BUY	$8.84 - $22.64 $138,434 - $354,542	15,660 New	15,660 $219,000
Q3 2019 Nov 14, 2019	SELL	$23.83 - $36.44 $1.5 Million - $2.29 Million	-62,863 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$32.75 - $40.35 $2.06 Million - $2.54 Million	62,863 New	62,863 $2.26 Million

130

35.9M

22K

93.8K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $242M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.